Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07406893 · ClinicalTrials.gov registry record · NA
Reduction of Bacterial Seeding in Total Shoulder Arthroplasty
A NA study of Prosthetic-joint Infection and Shoulder, sponsored by St. Louis University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07406893: Recruiting NA study of Prosthetic-joint Infection and Shoulder, sponsored by St. Louis University.
NCT07406893 is a NA study of Prosthetic-joint Infection and Shoulder that is actively recruiting participants, run by St. Louis University. The registered enrollment target is 60 participants, below the 92-participant average among 9 other Prosthetic-joint Infection trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07406893, a NA study of Prosthetic-joint Infection and Shoulder, is actively recruiting participants, sponsored by St. Louis University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the growth of intra-operative tissue cultures of Cutibacterium Acnes after primary shoulder replacement when using a no-prep control group versus Prontosan wound gel applied to the skin layer after the skin incision has been made.
Primary Outcome
Each participant will have culture swabs taken at the end of the surgical case from deep, superficial, and implant locations. Cultures will be held in the lab for 2 weeks to evaluate for the presence of bacteria.
Conditions Studied
Interventions
- DEVICE Prontosan Wound Gel
Study Locations (1)
Missouri
- Saint Louis University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-02-23 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07406893 shows while recruiting
NCT07406893 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 92-participant average among 9 other Prosthetic-joint Infection trials with a reported enrollment target (35% lower).
The record links to 4 conditions, with Prosthetic-joint Infection appearing as the primary indexed condition, and to 1 intervention - of which Prontosan Wound Gel is the first listed.
NCT07406893 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT07406893 about?
NCT07406893 is a clinical study titled "Reduction of Bacterial Seeding in Total Shoulder Arthroplasty". The purpose of this study is to compare the growth of intra-operative tissue cultures of Cutibacterium Acnes after primary shoulder replacement when using a no-prep control group versus Prontosan wound gel applied to the skin layer after the skin incision has been made.
What is the current status of trial NCT07406893?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-02-23. Estimated completion is 2026-12.
What conditions does trial NCT07406893 study?
This clinical trial studies the following conditions: Prosthetic-joint Infection, Shoulder, Cutibacterium Acnes, Joint Arthroplasty.
What interventions are being tested in trial NCT07406893?
The interventions under investigation include: Prontosan Wound Gel (DEVICE).
Who is sponsoring clinical trial NCT07406893?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07406893 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prosthetic-joint Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07406893's enrollment target sits among peer trials
60 6th of 9 higher than 3 of 9 other Prosthetic-joint Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prosthetic-joint Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Peri-Operative Adjunctive Probiotics on Immunological Markers in Cases of Prosthetic Joint Infection of the Hip and Knee
RECRUITING · NA
-
Real-component Vs All-cement Articulating Spacers for Periprosthetic Knee Infection
RECRUITING · NA
-
Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement
COMPLETED · NA
-
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
RECRUITING · Phase 2
-
A Second Trial of the Abbreviated Protocol Two-Stage Exchange
COMPLETED · Phase 2
-
SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI